Dysautonomia International

Pilot Study of Line-Field Confocal Optical Coherence Tomography for Detection of Mohs Micrographic Surgery Margins of Basal Cell Carcinomas

Purpose

To assess the feasibility and provide information on the utility of noninvasive line field confocal optical coherence tomography (LC-OCT) for the presurgical assessment of Mohs micrographic surgery sites in patients undergoing removal of cutaneous basal cell carcinomas (BCC).

Condition

Basal Cell Carcinoma

Eligibility

Eligible Ages: Over 18 Years
Eligible Sex: All
Accepts Healthy Volunteers: No

Inclusion Criteria

Age ≥ 18 years - Participant must understand the investigational nature of this study and provide written consent prior to receiving any study-related procedure. - Participant must be clinically eligible for Mohs surgery as determined by their referring dermatologist and the Mohs surgeon. - The participant must have a BCC with superficial histology or a BCC with multiple histological features that also include superficial histology, which is appropriate for Mohs surgery.

Exclusion Criteria

Known or reported allergy to mineral oil, the optical agent used during imaging. - Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements. - . Any condition which in the investigator's opinion deems the subject an unsuitable candidate to undergo imaging procedure. - Unwilling or unable to follow protocol requirements

Study Design

Phase: N/A
Study Type: Interventional
Allocation: N/A
Intervention Model: Single Group Assignment
Primary Purpose: Diagnostic
Masking: None (Open Label)

Arm Groups

Arm	Description	Assigned Intervention
Other Noninvasive Imaging Procedue -Line-field optical coherence tomography(LC-OCT)	LC-OCT imaging	Device: LC-OCT Imaging handheld imaging device will take high resolution images of lesion

Recruiting Locations

Roswell Park Comprehensive Cancer Center
Buffalo 5110629, New York 5128638 14263

More Details

Status: Recruiting
Sponsor: Roswell Park Cancer Institute

Study Contact

Ask RPCI
1-800-767-9355
askrpc@Roswellpark.org

Notice

Study information shown on this site is derived from ClinicalTrials.gov (a public registry operated by the National Institutes of Health). The listing of studies provided is not certain to be all studies for which you might be eligible. Furthermore, study eligibility requirements can be difficult to understand and may change over time, so it is wise to speak with your medical care provider and individual research study teams when making decisions related to participation.